Kalaris Therapeutics, Inc. · NASDAQ:KLRS

Srinivas Akkaraju reported a 54.20% stake in Kalaris Therapeutics, Inc. (Schedule 13D/A)

Event May 20, 2026 · Filed May 22, 2026

Srinivas Akkaraju reported a 54.20% stake in Kalaris Therapeutics, Inc., 12,900,583 shares, with active intent on May 20, 2026. Filed May 22, 2026 (Schedule 13D/A).

Stake
54.20%
Shares
12,900,583
Intent
Active
What changed
Stake changed
Filed together
5 holders

The filing in full

HolderStakeShares
Samsara BioCapital, L.P.44.80%10,657,028
Samsara BioCapital GP, LLC44.90%10,671,965
Samsara Opportunity Fund, L.P.9.30%2,224,147
Samsara Opportunity Fund GP, LLC9.30%2,224,147
Srinivas Akkaraju54.20%12,900,583

Source

View original at SEC

Related